Cerebrotendinous Xanthomatoses
6 clinical trials · Condition
◉ Watch Cerebrotendinous Xanthomatoses
| Record | Firm | Date |
|---|---|---|
| Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxycholic Acid Leadiant 250 mg Hard Capsules (250mg Chenodeoxycholic Acid) (NCT06180057) | Humanis Saglık Anonim Sirketi | 2022-06-12 |
| Early Check: Expanded Screening in Newborns (NCT03655223) | RTI International | 2018-10-15 |
| LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies (NCT02699190) | Children's Hospital of Philadelphia | 2017-01-06 |
| The Myelin Disorders Biorepository Project (NCT03047369) | Children's Hospital of Philadelphia | 2016-12-08 |
| Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanthomatosis (CTX) (NCT05499026) | Leadiant Biosciences Ltd. | 2014-12-09 |
Track Cerebrotendinous Xanthomatoses automatically
Every clearance here is in the API, with alerts when new ones post.